- Description
- Table of Contents
- Request Sample
The Viral Inactivation market is expected to reach $1,209.17 million by 2026 growing at a CAGR of 14.2% from 2018 to 2026. Viral inactivation is a dynamic component of the process of viral clearance that is compulsory for any phase of drug development. Regulatory officials such as the FDA have deepened the demand for viral inactivation in numerous applications including stem cell products, therapeutics, blood & blood products, tissue & tissue products, cell & gene treatment and vaccines. Factors such as increasing government support for pharmaceutical and biotechnology industries, an increase in the number of drug launches & approvals and rising investment in the life sciences sector are driving the market growth. Though, high cost of biologics and biosimilar products development & manufacturing restrain the market growth. Based on the product, Kits and reagents are expected to have a lucrative growth during the forecast period due to their continuous usage by pharmaceutical and biopharmaceutical companies. With an increase in the number of pharmaceutical and biopharmaceutical companies and the rise in R&D spending for the purpose of new drug development, the usage of kits and reagents has increased tremendously. The key vendors mentioned are Merck KGAA, Cerus Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Texcell, Inc., Parker Hannifin Corporation, Sanofi SA, SGS SA, Invitrogen Corp., General Electric Co., Rad Source Technologies, Qiagen NV, ZeptoMetrix Corp., MockV Solutions, Vironova AB, Viral Inactivated Plasma Systems SA, and BioReliance. Products Covered: • Services • Viral Inactivation Systems and Accessories • Kits and Reagents Methods Covered: • Pasteurization • Solvent Detergent Method • Other Methods Applications Covered: • Blood and Blood Products • Tissues and Tissue Products • Vaccines and Therapeutics • Stem Cell Products • Cellular and Gene Therapy Products End Users Covered: • Pharmaceutical and Biotechnology Companies • Academic Research Institutes • Contract Research Organizations • Blood Banks and Hospitals Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Viral Inactivation Market, By Product
5.1 Introduction
5.2 Services
5.3 Viral Inactivation Systems and Accessories
5.4 Kits and Reagents
6 Global Viral Inactivation Market, By Method
6.1 Introduction
6.2 Pasteurization
6.3 Solvent Detergent Method
6.4 Other Methods
7 Global Viral Inactivation Market, By Application
7.1 Introduction
7.2 Blood and Blood Products
7.3 Tissues and Tissue Products
7.4 Vaccines and Therapeutics
7.5 Stem Cell Products
7.6 Cellular and Gene Therapy Products
8 Global Viral Inactivation Market, By End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Academic Research Institutes
8.4 Contract Research Organizations
8.5 Blood Banks and Hospitals
9 Global Viral Inactivation Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa
10 Strategic Benchmarking
11 Vendors Landscape
11.1 Merck KGAA
11.2 Cerus Corporation
11.3 Thermo Fisher Scientific Inc.
11.4 Sartorius AG
11.5 Danaher Corporation
11.6 Texcell, Inc.
11.7 Parker Hannifin Corporation
11.8 Sanofi SA
11.9 SGS SA
11.10 Invitrogen Corp.
11.11 General Electric Co.
11.12 Rad Source Technologies
11.13 Qiagen NV
11.14 ZeptoMetrix Corp.
11.15 MockV Solutions
11.16 Vironova AB
11.17 Viral Inactivated Plasma Systems SA
11.18 BioReliance
List of Data Tables
Table 1 Global Viral Inactivation Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 3 Global Viral Inactivation Market Outlook, By Services (2016-2026) ($MN)
Table 4 Global Viral Inactivation Market Outlook, By Viral Inactivation Systems and Accessories (2016-2026) ($MN)
Table 5 Global Viral Inactivation Market Outlook, By Kits and Reagents (2016-2026) ($MN)
Table 6 Global Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 7 Global Viral Inactivation Market Outlook, By Pasteurization (2016-2026) ($MN)
Table 8 Global Viral Inactivation Market Outlook, By Solvent Detergent Method (2016-2026) ($MN)
Table 9 Global Viral Inactivation Market Outlook, By Other Methods (2016-2026) ($MN)
Table 10 Global Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 11 Global Viral Inactivation Market Outlook, By Blood and Blood Products (2016-2026) ($MN)
Table 12 Global Viral Inactivation Market Outlook, By Tissues and Tissue Products (2016-2026) ($MN)
Table 13 Global Viral Inactivation Market Outlook, By Vaccines and Therapeutics (2016-2026) ($MN)
Table 14 Global Viral Inactivation Market Outlook, By Stem Cell Products (2016-2026) ($MN)
Table 15 Global Viral Inactivation Market Outlook, By Cellular and Gene Therapy Products (2016-2026) ($MN)
Table 16 Global Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)
Table 17 Global Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology Companies (2016-2026) ($MN)
Table 18 Global Viral Inactivation Market Outlook, By Academic Research Institutes (2016-2026) ($MN)
Table 19 Global Viral Inactivation Market Outlook, By Contract Research Organizations (2016-2026) ($MN)
Table 20 Global Viral Inactivation Market Outlook, By Blood Banks and Hospitals (2016-2026) ($MN)
Table 21 North America Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 22 North America Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 23 North America Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 24 North America Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)
Table 25 Europe Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 26 Europe Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 27 Europe Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 28 Europe Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)
Table 29 Asia Pacific Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 30 Asia Pacific Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 31 Asia Pacific Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 32 Asia Pacific Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)
Table 33 South America Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 34 South America Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 35 South America Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 36 South America Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)
Table 37 Middle East & Africa Viral Inactivation Market Outlook, By Product (2016-2026) ($MN)
Table 38 Middle East & Africa Viral Inactivation Market Outlook, By Method (2016-2026) ($MN)
Table 39 Middle East & Africa Viral Inactivation Market Outlook, By Application (2016-2026) ($MN)
Table 40 Middle East & Africa Viral Inactivation Market Outlook, By End User (2016-2026) ($MN)